SCHEMBL2889156

SCHEMBL2889156

Cc1c(C(=O)O)sc2cccc([N+](=O)[O-])c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.53
TDP1 Q9NUW8 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPK1 P28482 1/20 0.44
MCL1 Q07820 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 3/20 0.42
LMNA P02545 2/20 0.41
ESR2 Q92731 1/20 0.41
GPR35 Q9HC97 3/20 0.40
MEN1 O00255 1/20 0.40
PTPN7 P35236 1/20 0.40
DUSP3 P51452 1/20 0.40
KMT2A Q03164 1/20 0.40
PTPN12 Q05209 1/20 0.40
PTPN22 Q9Y2R2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4272799 0.78 MCL1 (0.51) TSHRL3MBTL1MAPK1MCL1LMNA
SCHEMBL2897547 0.77 TSHR (0.53) TSHRTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL9567940 0.75 MCL1 (0.49) TSHRL3MBTL1MAPK1MCL1SMN1; SMN2
SCHEMBL2910452 0.75 ALDH1A1 (0.52) TSHRMAPK1MCL1SMN1; SMN2LMNA
SCHEMBL15619314 0.75 MCL1 (0.71) TSHRL3MBTL1MAPK1MCL1LMNA
SCHEMBL5035719 0.73 MCL1 (0.48) TSHRTDP1MAPK1MCL1SMN1; SMN2
SCHEMBL9567941 0.73 MCL1 (0.46) TSHRL3MBTL1MAPK1MCL1LMNA
SCHEMBL6233543 0.71 TDP1 (0.40) TSHRTDP1L3MBTL1SMN1; SMN2POLB
SCHEMBL9025199 0.70 STING1 (0.54) TSHRTDP1L3MBTL1MAPK1MCL1
SCHEMBL33663 0.69 TSHR (1.00) TSHRTDP1L3MBTL1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732477-B2 N-(1-azabicyclo[2.2.2]oct-3-yl)-heteroaryl carboxamides; alpha 7-nicotinic acetylcholine receptors (nAChR) agonists; improving perception, concentration, learning and memory; neuropathic pain; acute and chronic pain BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-08 US disclosed